Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

786 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 172
Recruiting: 93
Ph III recruiting: 9
Growth YoY: +32.4%
Industry share: 20%
Top sponsor: Ruijin Hospital
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (129)

clinicaltrialsPublishedShowing 301–350 of 400 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00038376	Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies	completed	Phase 2	56	M.D. Anderson Cancer CenterOTHER	1	Oct 29, 2018	clinicaltrials
NCT00958074	Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma	terminated	Phase 2	11	University of WashingtonOTHER	1	Oct 18, 2018	clinicaltrials
NCT03701022